Vanderbilt-Ingram Cancer Center Archive — Page 25 of 29

Multiple sagittal brain MRI scans arranged in a radiology film layout, with small technical labels throughout.
January 31, 2019

Grant supports novel imaging initiative to enhance cancer care

A Vanderbilt initiative to develop predictive imaging technologies that clinicians can use to better match patients with personalized care has received National Cancer Institute (NCI) funding.

Professional headshot of a smiling woman with shoulder-length brown hair wearing a black blazer.
October 4, 2018

VICC’s Levy to lead Rush University Cancer Center

Mia Levy, MD, PhD, director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Associate Professor of Cancer Research, has been named director of Rush University Cancer Center and Systems Vice President for Cancer Service at Rush University Medical Center in Chicago.

Head-and-shoulders portrait of a smiling man in a suit and tie.
May 17, 2018

Park named to VICC breast cancer leadership position

trailer park
January 18, 2018

Study finds higher death rates in poor neighborhoods

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.

Amanda Mathis poses with her hands resting on a glass railing in front of a large, partially visible logo and lettering.
November 9, 2017

Mathis strives to make her cancer journey meaningful

Amanda Mathis, chief financial officer of Bridgestone Americas, was just 35 when she first felt a lump in her right breast.

Two men sit in a medical examination room beside a computer displaying a scan. One wears a striped shirt and glasses; the other wears a white coat and ID badge.
October 25, 2017

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR-T therapy

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR-T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy.